论文信息 - Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial). - 字舞流文

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial).

H. Putter | T. Bosse | A. Westermann | J. Kroep | I. Boere | P. Witteveen | E. Meershoek-Klein Kranenbarg | C. Post | P. Ottevanger | J. Braak | C. Creutzberg | R. Lalisang | G. Sonke | I. Boere